{"id":76171,"date":"2026-10-12T19:54:40","date_gmt":"2026-10-12T19:54:40","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76171"},"modified":"2026-10-12T19:54:40","modified_gmt":"2026-10-12T19:54:40","slug":"u-s-analyst-updates-october-12th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/","title":{"rendered":"U.S. Analyst Updates: October 12th, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/strong><\/a><\/h2>\n

The October 12th U.S. analyst updates suggest a selective, cautious outlook, with price-target reductions outnumbering increases roughly two to one. Financials, insurance and real estate received more conservative valuations, although many bullish ratings were retained. Technology sentiment remained divided, combining selected upgrades and higher software targets with cuts across several major growth stocks. Energy showed stronger support through target increases, while healthcare and biotechnology attracted positive coverage alongside substantial differences in valuation.<\/p>\n

Updates (477)<\/strong><\/h3>\n

10x Genomics (TXG)<\/strong> \u2014 Canaccord Genuity maintained its Buy rating and raised its price target to US$100.00 from US$60.00.<\/p>\n

10x Genomics (TXG)<\/strong> \u2014 Morgan Stanley set a US$70.00 price target.<\/p>\n

Aardvark Therapeutics (AARD)<\/strong> \u2014 BTIG Research maintained its Neutral rating.<\/p>\n

AbCellera Biologics (ABCL)<\/strong> \u2014 UBS initiated coverage with a Buy rating and a US$18.00 price target.<\/p>\n

Absci (ABSI)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a US$16.00 price target.<\/p>\n

Adaptive Biotechnologies (ADPT)<\/strong> \u2014 Morgan Stanley set a US$27.00 price target.<\/p>\n

Adobe (ADBE)<\/strong> \u2014 Wells Fargo downgraded its rating to Underweight from Overweight and lowered its price target to US$225.00 from US$270.00.<\/p>\n

AerCap (AER)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$185.00 from US$180.00.<\/p>\n

AEVEX (AVEX)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$26.00 from US$31.00.<\/p>\n

Affiliated Managers Group (AMG)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$523.00 from US$512.00.<\/p>\n

Aflac (AFL)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$116.00 from US$122.00.<\/p>\n

Agilysys (AGYS)<\/strong> \u2014 Oppenheimer maintained its Outperform rating.<\/p>\n

Airbnb (ABNB)<\/strong> \u2014 Bernstein maintained its Outperform rating.<\/p>\n

Alexander’s (ALX)<\/strong> \u2014 Piper Sandler maintained its Underweight rating and lowered its price target to US$192.00 from US$212.00.<\/p>\n

Alexandria Real Estate Equities (ARE)<\/strong> \u2014 BMO Capital Markets downgraded its rating to Underperform from Market Perform with a US$41.00 price target.<\/p>\n

Alexandria Real Estate Equities (ARE)<\/strong> \u2014 Raymond James set a US$41.00 price target.<\/p>\n

Alexandria Real Estate Equities (ARE)<\/strong> \u2014 RBC Capital Markets set a US$41.00 price target.<\/p>\n

Alibaba Group (BABA)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$200.00 from US$210.00.<\/p>\n

Alignment Healthcare (ALHC)<\/strong> \u2014 Raymond James maintained its Outperform rating.<\/p>\n

Alignment Healthcare (ALHC)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$12.00 from US$21.00.<\/p>\n

Alignment Healthcare (ALHC)<\/strong> \u2014 UBS maintained its Neutral rating with a US$9.00 price target.<\/p>\n

AllianceBernstein (AB)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$36.00 from US$38.00.<\/p>\n

Alliant Energy (LNT)<\/strong> \u2014 Jefferies maintained its Buy rating with a US$75.00 price target.<\/p>\n

Allison Transmission (ALSN)<\/strong> \u2014 Citigroup upgraded its rating to Buy from Neutral with a US$135.00 price target.<\/p>\n

Allstate (ALL)<\/strong> \u2014 BofA Securities maintained its Buy rating and raised its price target to US$340.00 from US$336.00.<\/p>\n

Allstate (ALL)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Underperform rating and lowered its price target to US$232.00 from US$250.00.<\/p>\n

Allstate (ALL)<\/strong> \u2014 Wells Fargo upgraded its rating to Equal Weight from Underweight and lowered its price target to US$236.00 from US$250.00.<\/p>\n

Ally Financial (ALLY)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$43.00 from US$48.00.<\/p>\n

Ally Financial (ALLY)<\/strong> \u2014 Morgan Stanley downgraded its rating to Equal Weight from Overweight and lowered its price target to US$43.00 from US$55.00.<\/p>\n

Alphabet (GOOGL)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating with a US$420.00 price target.<\/p>\n

Amazon.com (AMZN)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to US$310.00 from US$320.00.<\/p>\n

Amazon.com (AMZN)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$329.00 from US$338.00.<\/p>\n

American Bitcoin (ABTC)<\/strong> \u2014 H.C. Wainwright resumed coverage with a Buy rating and a US$22.00 price target.<\/p>\n

American Bitcoin (ABTC)<\/strong> \u2014 Maxim Group set a US$16.00 price target.<\/p>\n

American Express (AXP)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$360.00 from US$400.00.<\/p>\n

American Express (AXP)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$380.00 from US$382.00.<\/p>\n

American Financial Group (AFG)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to US$147.00 from US$153.00.<\/p>\n

American Financial Group (AFG)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$166.00 from US$175.00.<\/p>\n

American Integrity Insurance Group (AII)<\/strong> \u2014 Citigroup maintained its Outperform rating.<\/p>\n

American Integrity Insurance Group (AII)<\/strong> \u2014 Citizens JMP maintained its Market Outperform rating and raised its price target to US$29.00 from US$26.00.<\/p>\n

American Integrity Insurance Group (AII)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and raised its price target to US$31.00 from US$29.00.<\/p>\n

American International Group (AIG)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to US$90.00 from US$96.00.<\/p>\n

American International Group (AIG)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$83.00 from US$85.00.<\/p>\n

American Savings Bank, N.A. (ASBH)<\/strong> \u2014 DA Davidson initiated coverage with a Buy rating and a US$20.00 price target.<\/p>\n

American Savings Bank, N.A. (ASBH)<\/strong> \u2014 Keefe, Bruyette & Woods initiated coverage with a Market Perform rating and a US$19.00 price target.<\/p>\n

American Savings Bank, N.A. (ASBH)<\/strong> \u2014 Piper Sandler initiated coverage with an Overweight rating and a US$20.00 price target.<\/p>\n

American Savings Bank, N.A. (ASBH)<\/strong> \u2014 Stephens initiated coverage with an Overweight rating and a US$21.00 price target.<\/p>\n

Americold Realty Trust (COLD)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$15.00 from US$17.00.<\/p>\n

AMERISAFE (AMSF)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

AMERISAFE (AMSF)<\/strong> \u2014 Citizens JMP maintained its Market Outperform rating and lowered its price target to US$40.00 from US$42.00.<\/p>\n

AMERISAFE (AMSF)<\/strong> \u2014 Morgan Stanley set a US$40.00 price target.<\/p>\n

AMETEK (AME)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$415.00 from US$450.00.<\/p>\n

Amgen (AMGN)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$430.00 from US$435.00.<\/p>\n

Amrize (AMRZ)<\/strong> \u2014 Longbow Research initiated coverage with a Buy rating.<\/p>\n

AON (AON)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to US$342.00 from US$417.00.<\/p>\n

AON (AON)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$323.00 from US$383.00.<\/p>\n

APA (APA)<\/strong> \u2014 Truist Securities maintained its Hold rating and raised its price target to US$45.00 from US$44.00.<\/p>\n

APA (APA)<\/strong> \u2014 UBS maintained its Neutral rating with a US$52.00 price target.<\/p>\n

APi Group (APG)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Apollo Global Management (APO)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$154.00 from US$159.00.<\/p>\n

AppLovin (APP)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to US$490.00 from US$560.00.<\/p>\n

Aptiv (APTV)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$77.00 from US$78.00.<\/p>\n

Aramark (ARMK)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Arch Capital Group (ACGL)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to US$95.00 from US$99.00.<\/p>\n

Arch Capital Group (ACGL)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$107.00 from US$117.00.<\/p>\n

Archer Daniels Midland (ADM)<\/strong> \u2014 JPMorgan maintained its Underweight rating and lowered its price target to US$75.00 from US$77.00.<\/p>\n

Ares Management (ARES)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$159.00 from US$163.00.<\/p>\n

argenx (ARGX)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to US$1,038.00 from US$1,100.00.<\/p>\n

Arthur J. Gallagher & Co. (AJG)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$284.00 from US$291.00.<\/p>\n

Artisan Partners Asset Management (APAM)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$33.00 from US$37.00.<\/p>\n

AST SpaceMobile (ASTS)<\/strong> \u2014 Deutsche Bank upgraded its rating to Buy from Hold with a US$93.00 price target.<\/p>\n

Ategrity Specialty (ASIC)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$31.00 from US$30.00.<\/p>\n

Atlassian (TEAM)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$235.00 from US$215.00.<\/p>\n

AtriCure (ATRC)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$63.00 from US$55.00.<\/p>\n

Autoliv (ALV)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$146.00 from US$147.00.<\/p>\n

Avery Dennison (AVY)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to US$208.00 from US$209.00.<\/p>\n

Avita Medical (RCEL)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$15.00 from US$11.00.<\/p>\n

Axis Capital (AXS)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$112.00 from US$126.00.<\/p>\n

AxoGen (AXGN)<\/strong> \u2014 BofA Securities initiated coverage with a Buy rating and a US$52.00 price target.<\/p>\n

Baldwin Insurance Group (BWIN)<\/strong> \u2014 Keefe, Bruyette & Woods downgraded its rating to Market Perform from Outperform with a US$32.50 price target.<\/p>\n

Baldwin Insurance Group (BWIN)<\/strong> \u2014 TD Cowen downgraded its rating to Hold from Buy and lowered its price target to US$32.50 from US$37.00.<\/p>\n

Beta Bionics (BBNX)<\/strong> \u2014 Jefferies initiated coverage with a Buy rating and a US$30.00 price target.<\/p>\n

Better Home & Finance (BETR)<\/strong> \u2014 BTIG Research maintained its Buy rating and lowered its price target to US$20.00 from US$23.00.<\/p>\n

BioAge Labs (BIOA)<\/strong> \u2014 UBS initiated coverage with a Neutral rating and a US$8.00 price target.<\/p>\n

Biogen (BIIB)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating with a US$220.00 price target.<\/p>\n

Biogen (BIIB)<\/strong> \u2014 JPMorgan upgraded its rating to Overweight from Neutral and raised its price target to US$300.00 from US$210.00.<\/p>\n

BioMarin Pharmaceutical (BMRN)<\/strong> \u2014 Raymond James upgraded its rating to Strong Buy from Outperform with a US$109.00 price target.<\/p>\n

BlackRock (BLK)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$1,212.00 from US$1,190.00.<\/p>\n

Blackstone (BX)<\/strong> \u2014 Citigroup upgraded its rating to Buy from Market Outperform.<\/p>\n

Blackstone (BX)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$144.00 from US$154.00.<\/p>\n

Blackstone Digital Infrastructure Trust (BXDC)<\/strong> \u2014 Citigroup upgraded its rating to Buy from Neutral and lowered its price target to US$20.00 from US$23.00.<\/p>\n

Blue Owl Capital (OWL)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$16.00 from US$15.00.<\/p>\n

Boeing (BA)<\/strong> \u2014 Bernstein maintained its Outperform rating and lowered its price target to US$278.00 from US$298.00.<\/p>\n

Booking (BKNG)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and lowered its price target to US$170.00 from US$220.00.<\/p>\n

Boyd Gaming (BYD)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

BRAEMAR HOTELS & RESORTS (BHR)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and lowered its price target to US$2.00 from US$2.50.<\/p>\n

Brixmor Property Group (BRX)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$36.00 from US$40.00.<\/p>\n

Brookfield Business (BBUC)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$29.00 from US$32.00.<\/p>\n

Brown & Brown (BRO)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

Brown & Brown (BRO)<\/strong> \u2014 Citizens JMP maintained its Market Outperform rating and lowered its price target to US$75.00 from US$78.00.<\/p>\n

Brown & Brown (BRO)<\/strong> \u2014 Keefe, Bruyette & Woods upgraded its rating to Outperform from Market Perform with a US$77.00 price target.<\/p>\n

Brown & Brown (BRO)<\/strong> \u2014 TD Cowen initiated coverage with a Buy rating and a US$82.00 price target.<\/p>\n

Brown & Brown (BRO)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$68.00 from US$69.00.<\/p>\n

Bunge Global (BG)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$139.00 from US$140.00.<\/p>\n

Butterfly Network (BFLY)<\/strong> \u2014 Canaccord Genuity initiated coverage with a Buy rating and a US$10.00 price target.<\/p>\n

BXP (BXP)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$72.00 from US$88.00.<\/p>\n

Byrna Technologies (BYRN)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to US$11.00 from US$12.00.<\/p>\n

C.H. Robinson Worldwide (CHRW)<\/strong> \u2014 Deutsche Bank downgraded its rating to Hold from Buy with a US$153.00 price target.<\/p>\n

C3.ai (AI)<\/strong> \u2014 Northland Securities upgraded its rating to Outperform from Market Perform and raised its price target to US$16.00 from US$10.00.<\/p>\n

California Resources (CRC)<\/strong> \u2014 UBS maintained its Buy rating.<\/p>\n

Camden Property Trust (CPT)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$102.00 from US$119.00.<\/p>\n

Capital One Financial (COF)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$227.00 from US$246.00.<\/p>\n

Capital One Financial (COF)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$267.00 from US$273.00.<\/p>\n

Carlsmed (CARL)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$24.00 from US$23.00.<\/p>\n

Carlyle Group (CG)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$42.00 from US$54.00.<\/p>\n

Carter’s (CRI)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$30.00 from US$42.00.<\/p>\n

Caterpillar (CAT)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Cencora (COR)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to US$373.00 from US$370.00.<\/p>\n

CenterPoint Energy (CNP)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to US$44.00 from US$46.00.<\/p>\n

Centerspace (CSR)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$56.00 from US$58.00.<\/p>\n

Charles River Laboratories International (CRL)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating with a US$340.00 price target.<\/p>\n

Charles Schwab (SCHW)<\/strong> \u2014 Evercore ISI initiated coverage with a In-Line rating and a US$107.00 price target.<\/p>\n

Charles Schwab (SCHW)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$129.00 from US$128.00.<\/p>\n

Chemung Financial (CHMG)<\/strong> \u2014 Hovde Group initiated coverage with a Market Perform rating and a US$88.00 price target.<\/p>\n

Chevron (CVX)<\/strong> \u2014 Mizuho set a US$234.00 price target.<\/p>\n

Chevron (CVX)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$225.00 from US$215.00.<\/p>\n

Choice Hotels International (CHH)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to US$92.00 from US$91.00.<\/p>\n

Chord Energy (CHRD)<\/strong> \u2014 Truist Securities maintained its Buy rating and raised its price target to US$195.00 from US$180.00.<\/p>\n

Chubb (CB)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to US$387.00 from US$389.00.<\/p>\n

Chubb (CB)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$343.00 from US$356.00.<\/p>\n

Cincinnati Financial (CINF)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to US$171.00 from US$190.00.<\/p>\n

Cipher Mining (CIFR)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$51.50 from US$54.00.<\/p>\n

Citizens (CIZN)<\/strong> \u2014 Morgan Stanley set a US$29.00 price target.<\/p>\n

Climb Bio (CLYM)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating.<\/p>\n

Cloudflare (NET)<\/strong> \u2014 Barclays maintained its Overweight rating with a US$400.00 price target.<\/p>\n

Community Financial System (CBU)<\/strong> \u2014 DA Davidson maintained its Neutral rating and lowered its price target to US$69.00 from US$70.00.<\/p>\n

Community Healthcare Trust (CHCT)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$14.00 from US$17.00.<\/p>\n

CommVault Systems (CVLT)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and raised its price target to US$160.00 from US$150.00.<\/p>\n

Compass (COMP)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$10.00 from US$13.00.<\/p>\n

Compugen (CGEN)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a US$4.00 price target.<\/p>\n

Connect Biopharma (CNTB)<\/strong> \u2014 Leerink Partners resumed coverage with an Outperform rating and a US$4.00 price target.<\/p>\n

Corebridge Financial (CRBG)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to US$40.00 from US$38.00.<\/p>\n

Corebridge Financial (CRBG)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$40.00 from US$39.00.<\/p>\n

Corteva (CTVA)<\/strong> \u2014 UBS set a US$15.00 price target.<\/p>\n

Crescent Energy (CRGY)<\/strong> \u2014 UBS maintained its Buy rating with a US$18.00 price target.<\/p>\n

Curbline Properties (CURB)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$38.00 from US$39.00.<\/p>\n

CVS Health (CVS)<\/strong> \u2014 Leerink Partners maintained its Outperform rating and lowered its price target to US$112.00 from US$119.00.<\/p>\n

D.R. Horton (DHI)<\/strong> \u2014 Goldman Sachs maintained its Buy rating with a US$182.00 price target.<\/p>\n

Danaher (DHR)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating with a US$240.00 price target.<\/p>\n

Darling Ingredients (DAR)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to US$83.00 from US$82.00.<\/p>\n

Datadog (DDOG)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$320.00 from US$280.00.<\/p>\n

Delta Air Lines (DAL)<\/strong> \u2014 Argus set a US$95.00 price target.<\/p>\n

Delta Air Lines (DAL)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and raised its price target to US$105.00 from US$100.00.<\/p>\n

Delta Air Lines (DAL)<\/strong> \u2014 Susquehanna set a US$95.00 price target.<\/p>\n

Delta Air Lines (DAL)<\/strong> \u2014 UBS set a US$102.00 price target.<\/p>\n

DexCom (DXCM)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$96.00 from US$90.00.<\/p>\n

DiamondRock Hospitality (DRH)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$12.00 from US$11.00.<\/p>\n

Dominion Energy (D)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to US$62.00 from US$66.00.<\/p>\n

DoorDash (DASH)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to US$240.00 from US$260.00.<\/p>\n

Douglas Emmett (DEI)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$11.00 from US$14.00.<\/p>\n

Dr. Reddy’s Laboratories (RDY)<\/strong> \u2014 BNP Paribas Exane upgraded its rating to Outperform with a US$14.80 price target.<\/p>\n

Duke Energy (DUK)<\/strong> \u2014 Jefferies maintained its Hold rating with a US$121.00 price target.<\/p>\n

Duke Energy (DUK)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to US$130.00 from US$135.00.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$73.00 from US$59.00.<\/p>\n

EastGroup Properties (EGP)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$246.00 from US$268.00.<\/p>\n

Eaton (ETN)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

eBay (EBAY)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$132.00 from US$127.00.<\/p>\n

eBay (EBAY)<\/strong> \u2014 Wells Fargo maintained its Underweight rating and lowered its price target to US$91.00 from US$92.00.<\/p>\n

Edison International (EIX)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to US$59.00 from US$61.00.<\/p>\n

Edison International (EIX)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to US$62.00 from US$63.00.<\/p>\n

Elevance Health (ELV)<\/strong> \u2014 Guggenheim maintained its Buy rating and raised its price target to US$460.00 from US$455.00.<\/p>\n

Eli Lilly and Company (LLY)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating with a US$1,500.00 price target.<\/p>\n

Enact Holdings (ACT)<\/strong> \u2014 JPMorgan downgraded its rating to Underweight from Neutral with a US$44.00 price target.<\/p>\n

Endava (DAVA)<\/strong> \u2014 Needham & Company maintained its Buy rating with a US$5.00 price target.<\/p>\n

Enovis (ENOV)<\/strong> \u2014 Needham & Company maintained its Buy rating and lowered its price target to US$34.00 from US$52.00.<\/p>\n

Entergy (ETR)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to US$119.00 from US$122.00.<\/p>\n

Equillium (EQ)<\/strong> \u2014 Leerink Partners resumed coverage with an Outperform rating and a US$6.00 price target.<\/p>\n

Equitable (EQH)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$65.00 from US$64.00.<\/p>\n

Essent Group (ESNT)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to US$66.00 from US$72.00.<\/p>\n

Essex Property Trust (ESS)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$326.00 from US$352.00.<\/p>\n

Ethos Technologies Inc. Class A Common Stock (LIFE)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

Ethos Technologies Inc. Class A Common Stock (LIFE)<\/strong> \u2014 Citizens JMP maintained its Market Outperform rating and raised its price target to US$40.00 from US$33.00.<\/p>\n

eToro Group (ETOR)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$33.00 from US$35.00.<\/p>\n

EVA Live (GOAI)<\/strong> \u2014 Maxim Group initiated coverage with a Buy rating and a US$7.00 price target.<\/p>\n

Everest Group (EG)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to US$407.00 from US$414.00.<\/p>\n

Everpure (P)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating.<\/p>\n

Everpure (P)<\/strong> \u2014 Guggenheim maintained its Buy rating and raised its price target to US$215.00 from US$150.00.<\/p>\n

Everspin Tech (MRAM)<\/strong> \u2014 Maxim Group initiated coverage with a Buy rating and a US$25.00 price target.<\/p>\n

Evommune (EVMN)<\/strong> \u2014 UBS initiated coverage with a Neutral rating and a US$8.00 price target.<\/p>\n

F5 (FFIV)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$525.00 from US$508.00.<\/p>\n

Fannie Mae (FNMA)<\/strong> \u2014 Mizuho downgraded its rating to Neutral from Outperform with a US$5.00 price target.<\/p>\n

Federal Realty Investment Trust (FRT)<\/strong> \u2014 Piper Sandler set a US$131.00 price target.<\/p>\n

Federated Hermes (FHI)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$56.00 from US$60.00.<\/p>\n

Figma (FIG)<\/strong> \u2014 Wells Fargo set a US$30.00 price target.<\/p>\n

First Financial Corporation (THFF)<\/strong> \u2014 Hovde Group initiated coverage with an Outperform rating and a US$85.00 price target.<\/p>\n

First Solar (FSLR)<\/strong> \u2014 Truist Securities upgraded its rating to Buy from Hold and raised its price target to US$270.00 from US$229.00.<\/p>\n

FirstEnergy (FE)<\/strong> \u2014 Mizuho set a US$47.00 price target.<\/p>\n

Ford Motor (F)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$16.00 from US$17.00.<\/p>\n

Fortinet (FTNT)<\/strong> \u2014 Barclays set a US$210.00 price target.<\/p>\n

Fortinet (FTNT)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and raised its price target to US$205.00 from US$185.00.<\/p>\n

Franklin Resources (BEN)<\/strong> \u2014 JPMorgan maintained its Neutral rating and raised its price target to US$35.00 from US$34.00.<\/p>\n

Franklin Resources (BEN)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$38.00 from US$40.00.<\/p>\n

Freddie Mac (FMCC)<\/strong> \u2014 Mizuho downgraded its rating to Neutral from Outperform with a US$4.00 price target.<\/p>\n

Fresenius Medical Care AG & Co. KGaA (FMS)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to US$24.00 from US$25.00.<\/p>\n

Frontdoor (FTDR)<\/strong> \u2014 Goldman Sachs maintained its Neutral rating and lowered its price target to US$81.00 from US$91.00.<\/p>\n

GE HealthCare Technologies (GEHC)<\/strong> \u2014 BTIG Research maintained its Buy rating and lowered its price target to US$75.00 from US$79.00.<\/p>\n

Gen Digital (GEN)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and lowered its price target to US$24.00 from US$26.00.<\/p>\n

General Motors (GM)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$110.00 from US$120.00.<\/p>\n

General Motors (GM)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$102.00 from US$100.00.<\/p>\n

Genuine Parts (GPC)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to US$137.00 from US$125.00.<\/p>\n

Gilead Sciences (GILD)<\/strong> \u2014 BofA Securities maintained its Buy rating with a US$164.00 price target.<\/p>\n

Glaukos (GKOS)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$205.00 from US$202.00.<\/p>\n

Globe Life (GL)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$191.00 from US$190.00.<\/p>\n

GoDaddy (GDDY)<\/strong> \u2014 RBC Capital Markets downgraded its rating to Sector Perform from Outperform with a US$95.00 price target.<\/p>\n

Goosehead Insurance (GSHD)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

Goosehead Insurance (GSHD)<\/strong> \u2014 Citizens JMP maintained its Market Outperform rating and lowered its price target to US$80.00 from US$100.00.<\/p>\n

Goosehead Insurance (GSHD)<\/strong> \u2014 Deutsche Bank set a US$80.00 price target.<\/p>\n

Goosehead Insurance (GSHD)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Outperform rating and lowered its price target to US$66.00 from US$72.00.<\/p>\n

GRAIL (GRAL)<\/strong> \u2014 Morgan Stanley set a US$120.00 price target.<\/p>\n

Graphic Packaging (GPK)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to US$9.00 from US$11.00.<\/p>\n

Greif (GEF)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to US$94.00 from US$97.00.<\/p>\n

Guardant Health (GH)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating with a US$200.00 price target.<\/p>\n

Hamilton Insurance Group (HG)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$40.00 from US$41.00.<\/p>\n

Harmony Biosciences (HRMY)<\/strong> \u2014 Needham & Company maintained its Buy rating with a US$50.00 price target.<\/p>\n

HCA Healthcare (HCA)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$460.00 from US$431.00.<\/p>\n

Helmerich & Payne (HP)<\/strong> \u2014 BofA Securities maintained its Buy rating.<\/p>\n

Helmerich & Payne (HP)<\/strong> \u2014 UBS maintained its Buy rating with a US$50.00 price target.<\/p>\n

Hemab Therapeutics (COAG)<\/strong> \u2014 Rodman & Renshaw initiated coverage with a Buy rating and a US$56.00 price target.<\/p>\n

Herc (HRI)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Hexcel (HXL)<\/strong> \u2014 Seaport Research Partners upgraded its rating to Buy from Neutral with a US$104.00 price target.<\/p>\n

Hilton Worldwide (HLT)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$336.00 from US$332.00.<\/p>\n

Hinge Health (HNGE)<\/strong> \u2014 Barclays maintained its Overweight rating with a US$110.00 price target.<\/p>\n

Host Hotels & Resorts (HST)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$24.00 from US$22.00.<\/p>\n

Howard Hughes (HHH)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$83.00 from US$100.00.<\/p>\n

Hub Group (HUBG)<\/strong> \u2014 Robert W. Baird upgraded its rating to Outperform from Neutral with a US$29.00 price target.<\/p>\n

HubSpot (HUBS)<\/strong> \u2014 Barclays downgraded its rating to Equal Weight from Overweight with a US$240.00 price target.<\/p>\n

HubSpot (HUBS)<\/strong> \u2014 UBS downgraded its rating to Cautious from Positive with a US$240.00 price target.<\/p>\n

Hudson Pacific Properties (HPP)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$15.00 from US$18.00.<\/p>\n

Humana (HUM)<\/strong> \u2014 Oppenheimer set a US$525.00 price target.<\/p>\n

Humana (HUM)<\/strong> \u2014 Raymond James upgraded its rating to Outperform from Market Perform with a US$520.00 price target.<\/p>\n

Humana (HUM)<\/strong> \u2014 Truist Securities maintained its Hold rating and raised its price target to US$475.00 from US$415.00.<\/p>\n

Humana (HUM)<\/strong> \u2014 UBS maintained its Neutral rating.<\/p>\n

Hyatt Hotels (H)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$211.00 from US$209.00.<\/p>\n

IDEXX Laboratories (IDXX)<\/strong> \u2014 KeyBanc Capital Markets initiated coverage with a Sector Weight rating.<\/p>\n

IDEXX Laboratories (IDXX)<\/strong> \u2014 KeyCorp initiated coverage with a Sector Weight rating.<\/p>\n

Ingersoll Rand (IR)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Innovative Industrial Properties (IIPR)<\/strong> \u2014 Piper Sandler maintained its Underweight rating and lowered its price target to US$44.00 from US$51.00.<\/p>\n

Insmed (INSM)<\/strong> \u2014 BofA Securities maintained its Buy rating with a US$207.00 price target.<\/p>\n

Insmed (INSM)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a US$220.00 price target.<\/p>\n

Insmed (INSM)<\/strong> \u2014 Wolfe Research downgraded its rating to Peer Perform from Outperform.<\/p>\n

Installed Building Products (IBP)<\/strong> \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to US$257.00 from US$297.00.<\/p>\n

Insulet (PODD)<\/strong> \u2014 Jefferies maintained its Buy rating and lowered its price target to US$190.00 from US$275.00.<\/p>\n

Intapp (INTA)<\/strong> \u2014 Barclays maintained its Underweight rating with a US$38.00 price target.<\/p>\n

Interactive Brokers Group (IBKR)<\/strong> \u2014 Deutsche Bank initiated coverage with a Buy rating and a US$102.00 price target.<\/p>\n

Interactive Brokers Group (IBKR)<\/strong> \u2014 Evercore ISI initiated coverage with an Outperform rating and a US$100.00 price target.<\/p>\n

Intercontinental Exchange (ICE)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$167.00 from US$166.00.<\/p>\n

International Paper (IP)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to US$41.00 from US$49.00.<\/p>\n

Intuitive Surgical (ISRG)<\/strong> \u2014 BTIG Research maintained its Buy rating and lowered its price target to US$454.00 from US$469.00.<\/p>\n

Invesco (IVZ)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$38.00 from US$39.00.<\/p>\n

Invitation Home (INVH)<\/strong> \u2014 UBS maintained its Buy rating with a US$31.00 price target.<\/p>\n

Kardigan (KARD)<\/strong> \u2014 UBS initiated coverage with a Buy rating and a US$25.00 price target.<\/p>\n

KB Home (KBH)<\/strong> \u2014 Goldman Sachs set a US$56.00 price target.<\/p>\n

Kimball Electronics (KE)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating.<\/p>\n

Kimco Realty (KIM)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$27.00 from US$31.00.<\/p>\n

Kinsale Capital Group (KNSL)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$348.00 from US$377.00.<\/p>\n

Kite Realty Group Trust (KRG)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$27.00 from US$33.00.<\/p>\n

KKR & Co. Inc. (KKR)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$103.00 from US$118.00.<\/p>\n

Kodiak Gas Services (KGS)<\/strong> \u2014 Mizuho set a US$72.00 price target.<\/p>\n

Kodiak Sciences (KOD)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating and raised its price target to US$126.00 from US$96.00.<\/p>\n

Kratos Defense & Security Solutions (KTOS)<\/strong> \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to US$77.00 from US$88.00.<\/p>\n

L3Harris Technologies (LHX)<\/strong> \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to US$361.00 from US$405.00.<\/p>\n

Las Vegas Sands (LVS)<\/strong> \u2014 Citigroup initiated coverage with a Buy rating and a US$71.50 price target.<\/p>\n

Latham Group (SWIM)<\/strong> \u2014 Goldman Sachs maintained its Sell rating.<\/p>\n

LB Pharmaceuticals (LBRX)<\/strong> \u2014 Guggenheim maintained its Buy rating.<\/p>\n

LB Pharmaceuticals (LBRX)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating.<\/p>\n

LB Pharmaceuticals (LBRX)<\/strong> \u2014 Raymond James upgraded its rating to Buy.<\/p>\n

Lear (LEA)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and lowered its price target to US$139.00 from US$143.00.<\/p>\n

Lincoln National (LNC)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$54.00 from US$52.00.<\/p>\n

Lineage (LINE)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$36.00 from US$44.00.<\/p>\n

Louisiana-Pacific (LPX)<\/strong> \u2014 Goldman Sachs maintained its Sell rating and lowered its price target to US$64.00 from US$74.00.<\/p>\n

LPL Financial (LPLA)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$380.00 from US$377.00.<\/p>\n

Lucid Group (LCID)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating.<\/p>\n

Lucid Group (LCID)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and lowered its price target to US$4.00 from US$7.00.<\/p>\n

Macerich (MAC)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$26.00 from US$30.00.<\/p>\n

Madison Air Solutions (MAIR)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Magna International (MGA)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and lowered its price target to US$68.00 from US$69.00.<\/p>\n

Manhattan Associates (MANH)<\/strong> \u2014 Morgan Stanley upgraded its rating to Overweight from Equal Weight and raised its price target to US$250.00 from US$180.00.<\/p>\n

Marriott International (MAR)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$384.00 from US$380.00.<\/p>\n

Marsh & McLennan Companies (MRSH)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$183.00 from US$188.00.<\/p>\n

MasTec (MTZ)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating with a US$348.00 price target.<\/p>\n

Mattel (MAT)<\/strong> \u2014 Seaport Research Partners upgraded its rating to Buy from Neutral with a US$20.00 price target.<\/p>\n

MBX Biosciences (MBX)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to US$84.00 from US$70.00.<\/p>\n

Medtronic (MDT)<\/strong> \u2014 BTIG Research maintained its Buy rating and lowered its price target to US$99.00 from US$100.00.<\/p>\n

Melco Resorts & Entertainment (MLCO)<\/strong> \u2014 Citigroup initiated coverage with a Buy rating and a US$9.40 price target.<\/p>\n

MercadoLibre (MELI)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to US$2,200.00 from US$2,300.00.<\/p>\n

Merck & Co., Inc. (MRK)<\/strong> \u2014 RBC Capital Markets maintained its Sector Perform rating and lowered its price target to US$145.00 from US$150.00.<\/p>\n

Meritage Homes (MTH)<\/strong> \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to US$82.00 from US$93.00.<\/p>\n

Meta Platforms (META)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to US$840.00 from US$860.00.<\/p>\n

MetLife (MET)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$110.00 from US$109.00.<\/p>\n

MGM Resorts International (MGM)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

Microsoft (MSFT)<\/strong> \u2014 Deutsche Bank maintained its Buy rating with a US$600.00 price target.<\/p>\n

Mid-America Apartment Communities (MAA)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$121.00 from US$140.00.<\/p>\n

Mineralys Therapeutics (MLYS)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a US$56.00 price target.<\/p>\n

Mineralys Therapeutics (MLYS)<\/strong> \u2014 UBS initiated coverage with a Neutral rating and a US$29.00 price target.<\/p>\n

MiniMed Group (MMED)<\/strong> \u2014 Jefferies initiated coverage with a Hold rating and a US$22.00 price target.<\/p>\n

Mirum Pharmaceuticals (MIRM)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating and raised its price target to US$200.00 from US$195.00.<\/p>\n

Mirum Pharmaceuticals (MIRM)<\/strong> \u2014 TD Cowen maintained its Buy rating.<\/p>\n

monday.com (MNDY)<\/strong> \u2014 Barclays downgraded its rating to Equal Weight from Overweight with a US$100.00 price target.<\/p>\n

Nasdaq (NDAQ)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$107.00 from US$108.00.<\/p>\n

Natera (NTRA)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating with a US$435.00 price target.<\/p>\n

Navient (NAVI)<\/strong> \u2014 JPMorgan maintained its Neutral rating and raised its price target to US$8.50 from US$8.00.<\/p>\n

nCino (NCNO)<\/strong> \u2014 KeyCorp maintained its Sector Weight rating.<\/p>\n

Nektar Therapeutics (NKTR)<\/strong> \u2014 Leerink Partners initiated coverage with an Outperform rating and a US$130.00 price target.<\/p>\n

Nektar Therapeutics (NKTR)<\/strong> \u2014 UBS initiated coverage with a Neutral rating and a US$53.00 price target.<\/p>\n

Neptune Insurance (NP)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$34.00 from US$37.00.<\/p>\n

Neurocrine Biosciences (NBIX)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$150.00 from US$164.00.<\/p>\n

Newmark Group (NMRK)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$14.00 from US$19.00.<\/p>\n

NMI (NMIH)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$45.00 from US$50.00.<\/p>\n

Norwegian Cruise Line (NCLH)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$18.00 from US$20.00.<\/p>\n

Novo Nordisk A\/S (NVO)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$40.00 from US$47.00.<\/p>\n

Nutrien (NTR)<\/strong> \u2014 Jefferies maintained its Hold rating with a US$71.00 price target.<\/p>\n

nVent Electric (NVT)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

O-I Glass (OI)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to US$8.00 from US$10.00.<\/p>\n

Ocular Therapeutix (OCUL)<\/strong> \u2014 UBS initiated coverage with a Buy rating and a US$14.00 price target.<\/p>\n

Odyssey Therapeutics (ODTX)<\/strong> \u2014 UBS initiated coverage with a Buy rating and a US$27.00 price target.<\/p>\n

Ollie’s Bargain Outlet (OLLI)<\/strong> \u2014 Piper Sandler maintained its Overweight rating.<\/p>\n

OneMain (OMF)<\/strong> \u2014 JPMorgan maintained its Underweight rating and lowered its price target to US$52.00 from US$60.00.<\/p>\n

Onity Group (ONIT)<\/strong> \u2014 BTIG Research maintained its Buy rating and lowered its price target to US$45.00 from US$50.00.<\/p>\n

Option Care Health (OPCH)<\/strong> \u2014 Morgan Stanley set a US$32.05 price target.<\/p>\n

Oscar Health (OSCR)<\/strong> \u2014 UBS maintained its Neutral rating with a US$36.00 price target.<\/p>\n

Ovintiv (OVV)<\/strong> \u2014 Truist Securities maintained its Buy rating and raised its price target to US$77.00 from US$73.00.<\/p>\n

Owens Corning (OC)<\/strong> \u2014 Goldman Sachs maintained its Neutral rating and lowered its price target to US$128.00 from US$169.00.<\/p>\n

Pacific Gas & Electric (PCG)<\/strong> \u2014 Barclays set a US$17.00 price target.<\/p>\n

Pacific Gas & Electric (PCG)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$17.00 from US$18.00.<\/p>\n

Packaging Corporation of America (PKG)<\/strong> \u2014 Truist Securities maintained its Buy rating and raised its price target to US$280.00 from US$270.00.<\/p>\n

Palantir Technologies (PLTR)<\/strong> \u2014 Robert W. Baird set a US$250.00 price target.<\/p>\n

Palo Alto Networks (PANW)<\/strong> \u2014 Wells Fargo maintained its Overweight rating with a US$525.00 price target.<\/p>\n

Palvella Therapeutics (PVLA)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating and lowered its price target to US$246.00 from US$270.00.<\/p>\n

Park Hotels & Resorts (PK)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$13.00 from US$11.00.<\/p>\n

Parker-Hannifin (PH)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Pebblebrook Hotel Trust (PEB)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to US$14.00 from US$13.00.<\/p>\n

PennyMac Financial Services (PFSI)<\/strong> \u2014 BTIG Research maintained its Buy rating and lowered its price target to US$80.00 from US$90.00.<\/p>\n

Permian Resources (PR)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Permian Resources (PR)<\/strong> \u2014 Truist Securities maintained its Buy rating and raised its price target to US$28.00 from US$24.00.<\/p>\n

Phreesia (PHR)<\/strong> \u2014 Barclays set a US$11.00 price target.<\/p>\n

PPL (PPL)<\/strong> \u2014 Barclays maintained its Overweight rating with a US$38.00 price target.<\/p>\n

Principal Financial Group (PFG)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$113.00 from US$115.00.<\/p>\n

Promis Neurosciences (PMN)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating.<\/p>\n

Protagonist Therapeutics (PTGX)<\/strong> \u2014 Leerink Partners maintained its Outperform rating and raised its price target to US$190.00 from US$150.00.<\/p>\n

Protagonist Therapeutics (PTGX)<\/strong> \u2014 UBS initiated coverage with a Buy rating and a US$184.00 price target.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 Mizuho set a US$108.00 price target.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$120.00 from US$128.00.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 Wells Fargo maintained its Underweight rating and lowered its price target to US$104.00 from US$110.00.<\/p>\n

PulteGroup (PHM)<\/strong> \u2014 Goldman Sachs set a US$138.00 price target.<\/p>\n

Q32 Bio (QTTB)<\/strong> \u2014 Leerink Partners initiated coverage with an Outperform rating and a US$40.00 price target.<\/p>\n

Quoin Pharmaceuticals (QNRX)<\/strong> \u2014 BTIG Research initiated coverage with a Buy rating and a US$14.00 price target.<\/p>\n

Ralliant (RAL)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Rayonier (RYN)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to US$22.00 from US$24.00.<\/p>\n

Red Rock Resorts (RRR)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Regal Rexnord (RRX)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Reinsurance Group of America (RGA)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$292.00 from US$291.00.<\/p>\n

RenaissanceRe (RNR)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$320.00 from US$315.00.<\/p>\n

RenaissanceRe (RNR)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$319.00 from US$331.00.<\/p>\n

Rexford Industrial Realty (REXR)<\/strong> \u2014 Truist Securities maintained its Buy rating and raised its price target to US$39.00 from US$38.00.<\/p>\n

Rhythm Pharmaceuticals (RYTM)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating and raised its price target to US$130.00 from US$105.00.<\/p>\n

Rithm Capital (RITM)<\/strong> \u2014 BTIG Research maintained its Buy rating and lowered its price target to US$12.00 from US$13.00.<\/p>\n

RLI (RLI)<\/strong> \u2014 Wells Fargo maintained its Underweight rating and lowered its price target to US$51.00 from US$57.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 Evercore ISI initiated coverage with an Outperform rating and a US$130.00 price target.<\/p>\n

Roblox (RBLX)<\/strong> \u2014 Wells Fargo downgraded its rating to Cautious from Overweight.<\/p>\n

Rocket Companies (RKT)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to US$12.50 from US$14.00.<\/p>\n

Rocket Companies (RKT)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$16.00 from US$19.00.<\/p>\n

Roivant Sciences (ROIV)<\/strong> \u2014 Wolfe Research downgraded its rating to Peer Perform from Outperform.<\/p>\n

Royal Caribbean Cruises (RCL)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$358.00 from US$388.00.<\/p>\n

Ryan Specialty (RYAN)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$41.00 from US$43.00.<\/p>\n

SailPoint (SAIL)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating.<\/p>\n

SailPoint (SAIL)<\/strong> \u2014 Stephens maintained its Overweight rating.<\/p>\n

Salesforce (CRM)<\/strong> \u2014 Barclays downgraded its rating to Positive from Overweight.<\/p>\n

Salesforce (CRM)<\/strong> \u2014 BofA Securities upgraded its rating to Buy from Underperform and raised its price target to US$285.00 from US$160.00.<\/p>\n

Salesforce (CRM)<\/strong> \u2014 Deutsche Bank initiated coverage with a Buy rating.<\/p>\n

Salesforce (CRM)<\/strong> \u2014 Evercore ISI initiated coverage with an Outperform rating.<\/p>\n

Salesforce (CRM)<\/strong> \u2014 KeyCorp initiated coverage with a Sector Weight rating.<\/p>\n

Salesforce (CRM)<\/strong> \u2014 TD Cowen initiated coverage with a Buy rating.<\/p>\n

Salesforce (CRM)<\/strong> \u2014 Wells Fargo downgraded its rating to Underweight from Buy.<\/p>\n

Schrodinger (SDGR)<\/strong> \u2014 BMO Capital Markets maintained its Outperform rating and raised its price target to US$30.00 from US$24.00.<\/p>\n

Sempra Energy (SRE)<\/strong> \u2014 Barclays maintained its Overweight rating with a US$90.00 price target.<\/p>\n

Sempra Energy (SRE)<\/strong> \u2014 JPMorgan maintained its Overweight rating and lowered its price target to US$99.00 from US$102.00.<\/p>\n

ServiceNow (NOW)<\/strong> \u2014 BTIG Research maintained its Buy rating with a US$170.00 price target.<\/p>\n

ServiceNow (NOW)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$176.00 from US$130.00.<\/p>\n

ServiceNow (NOW)<\/strong> \u2014 Wells Fargo maintained its Overweight rating with a US$190.00 price target.<\/p>\n

Shattuck Labs (STTK)<\/strong> \u2014 UBS initiated coverage with a Buy rating and a US$17.00 price target.<\/p>\n

Shell (SHEL)<\/strong> \u2014 Mizuho set a US$103.00 price target.<\/p>\n

Shopify (SHOP)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and raised its price target to US$158.00 from US$145.00.<\/p>\n

Shoulder Innovations (SI)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$27.00 from US$26.00.<\/p>\n

Silgan (SLGN)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to US$45.00 from US$52.00.<\/p>\n

Simon Property Group (SPG)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$254.00 from US$285.00.<\/p>\n

SiteOne Landscape Supply (SITE)<\/strong> \u2014 Goldman Sachs set a US$100.00 price target.<\/p>\n

Skyward Specialty Insurance Group (SKWD)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

SL Green Realty (SLG)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$64.00 from US$79.00.<\/p>\n

Slide Insurance (SLDE)<\/strong> \u2014 Citigroup maintained its Outperform rating.<\/p>\n

Slide Insurance (SLDE)<\/strong> \u2014 Citizens JMP maintained its Market Outperform rating and raised its price target to US$28.00 from US$27.00.<\/p>\n

SLM Corporation (Sallie Mae) (SLM)<\/strong> \u2014 JPMorgan maintained its Underweight rating and lowered its price target to US$22.00 from US$25.00.<\/p>\n

SLM Corporation (Sallie Mae) (SLM)<\/strong> \u2014 Morgan Stanley upgraded its rating to Overweight from Equal Weight with a US$30.00 price target.<\/p>\n

Smurfit Westrock (SW)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to US$54.00 from US$57.00.<\/p>\n

Snowflake (SNOW)<\/strong> \u2014 Needham & Company maintained its Buy rating with a US$450.00 price target.<\/p>\n

SoFi Technologies (SOFI)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Underperform rating.<\/p>\n

Sonoco Products (SON)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to US$62.00 from US$68.00.<\/p>\n

SOPHiA GENETICS (SOPH)<\/strong> \u2014 H.C. Wainwright maintained its Buy rating with a US$14.00 price target.<\/p>\n

SpaceX (SPCX)<\/strong> \u2014 Pivotal Research maintained its Buy rating with a US$230.00 price target.<\/p>\n

Spotify Technology (SPOT)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and lowered its price target to US$490.00 from US$530.00.<\/p>\n

Spyre Therapeutics (SYRE)<\/strong> \u2014 UBS initiated coverage with a Buy rating and a US$120.00 price target.<\/p>\n

Standard Motor Products (SMP)<\/strong> \u2014 Roth Capital maintained its Buy rating with a US$54.00 price target.<\/p>\n

Stewart Information Services (STC)<\/strong> \u2014 Citigroup maintained its Market Outperform rating.<\/p>\n

Stewart Information Services (STC)<\/strong> \u2014 Citizens JMP maintained its Market Outperform rating and lowered its price target to US$75.00 from US$80.00.<\/p>\n

Stifel Financial (SF)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$78.00 from US$84.00.<\/p>\n

Strive (ASST)<\/strong> \u2014 Maxim Group set a US$37.00 price target.<\/p>\n

Stryker (SYK)<\/strong> \u2014 BTIG Research maintained its Buy rating and lowered its price target to US$316.00 from US$358.00.<\/p>\n

Sylvamo (SLVM)<\/strong> \u2014 Truist Securities maintained its Buy rating and lowered its price target to US$40.00 from US$49.00.<\/p>\n

Synchrony Financial (SYF)<\/strong> \u2014 JPMorgan maintained its Neutral rating and lowered its price target to US$74.00 from US$78.00.<\/p>\n

Synchrony Financial (SYF)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$83.00 from US$84.00.<\/p>\n

Synopsys (SNPS)<\/strong> \u2014 Needham & Company maintained its Buy rating and raised its price target to US$620.00 from US$580.00.<\/p>\n

T-Mobile US (TMUS)<\/strong> \u2014 Raymond James upgraded its rating to Outperform from Market Perform with a US$170.00 price target.<\/p>\n

T. Rowe Price Group (TROW)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$109.00 from US$110.00.<\/p>\n

Tactile Systems Technology (TCMD)<\/strong> \u2014 BTIG Research maintained its Buy rating and lowered its price target to US$35.00 from US$39.00.<\/p>\n

Take-Two Interactive Software (TTWO)<\/strong> \u2014 Wells Fargo maintained its Overweight rating.<\/p>\n

Targa Resources (TRGP)<\/strong> \u2014 Citigroup raised its price target to US$325.00 from US$303.00.<\/p>\n

Tectonic Therapeutic (TECX)<\/strong> \u2014 UBS initiated coverage with a Neutral rating and a US$26.00 price target.<\/p>\n

Tempus AI (TEM)<\/strong> \u2014 Canaccord Genuity maintained its Buy rating and raised its price target to US$95.00 from US$80.00.<\/p>\n

TeraWulf (WULF)<\/strong> \u2014 TD Cowen initiated coverage with a Buy rating and a US$21.00 price target.<\/p>\n

Terreno Realty (TRNO)<\/strong> \u2014 BMO Capital Markets upgraded its rating to Outperform from Market Perform with a US$75.00 price target.<\/p>\n

Terreno Realty (TRNO)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$85.00 from US$91.00.<\/p>\n

Tesla (TSLA)<\/strong> \u2014 Jefferies maintained its Hold rating and raised its price target to US$400.00 from US$350.00.<\/p>\n

Teva Pharmaceutical Industries (TEVA)<\/strong> \u2014 JPMorgan maintained its Overweight rating and raised its price target to US$50.00 from US$40.00.<\/p>\n

The Hartford Insurance Group (HIG)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Market Perform rating and lowered its price target to US$137.00 from US$144.00.<\/p>\n

The Hartford Insurance Group (HIG)<\/strong> \u2014 Truist Securities initiated coverage with a Hold rating and a US$137.00 price target.<\/p>\n

The Hartford Insurance Group (HIG)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$158.00 from US$164.00.<\/p>\n

Thermo Fisher Scientific (TMO)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating with a US$730.00 price target.<\/p>\n

TPG (TPG)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$60.00 from US$64.00.<\/p>\n

Tractor Supply (TSCO)<\/strong> \u2014 UBS maintained its Neutral rating.<\/p>\n

Transdigm Group (TDG)<\/strong> \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to US$1,745.00 from US$1,972.00.<\/p>\n

Twist Bioscience (TWST)<\/strong> \u2014 Canaccord Genuity maintained its Buy rating and raised its price target to US$205.00 from US$120.00.<\/p>\n

Tyler Technologies (TYL)<\/strong> \u2014 Wells Fargo upgraded its rating to Overweight from Equal Weight and raised its price target to US$400.00 from US$335.00.<\/p>\n

Uber Technologies (UBER)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating with a US$90.00 price target.<\/p>\n

UL Solutions (ULS)<\/strong> \u2014 UBS maintained its Buy rating with a US$97.00 price target.<\/p>\n

Unilever (UL)<\/strong> \u2014 Jefferies maintained its Underperform rating.<\/p>\n

United Dominion Realty Trust (UDR)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$36.00 from US$41.00.<\/p>\n

Unity Software (U)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$53.00 from US$48.00.<\/p>\n

Unum Group (UNM)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and raised its price target to US$102.00 from US$100.00.<\/p>\n

UWM (UWMC)<\/strong> \u2014 BTIG Research downgraded its rating to Neutral from Buy.<\/p>\n

UWM (UWMC)<\/strong> \u2014 Morgan Stanley set a US$1.50 price target.<\/p>\n

V.F. (VFC)<\/strong> \u2014 Barclays maintained its Overweight rating.<\/p>\n

Vail Resorts (MTN)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to US$172.00 from US$157.00.<\/p>\n

Vaxcyte (PCVX)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating with a US$120.00 price target.<\/p>\n

Vera Therapeutics (VERA)<\/strong> \u2014 Leerink Partners initiated coverage with a Market Perform rating and a US$34.00 price target.<\/p>\n

Versigent (VGNT)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to US$53.00 from US$52.00.<\/p>\n

Virtus Investment Partners (VRTS)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$136.00 from US$155.00.<\/p>\n

Visa (V)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to US$430.00 from US$420.00.<\/p>\n

Visteon (VC)<\/strong> \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to US$127.00 from US$129.00.<\/p>\n

Vivmark Residential Common Shares of Beneficial Interest (VMRK)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$67.00 from US$76.00.<\/p>\n

Vornado Realty Trust (VNO)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$37.00 from US$44.00.<\/p>\n

Voya Financial (VOYA)<\/strong> \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to US$102.00 from US$104.00.<\/p>\n

Vylor (VYLR)<\/strong> \u2014 UBS initiated coverage with a Buy rating and a US$89.00 price target.<\/p>\n

W.R. Berkley (WRB)<\/strong> \u2014 Wells Fargo maintained its Underweight rating and lowered its price target to US$65.00 from US$68.00.<\/p>\n

Watsco (WSO)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$330.00 from US$370.00.<\/p>\n

Western Digital (WDC)<\/strong> \u2014 UBS set a US$470.00 price target.<\/p>\n

Weyerhaeuser (WY)<\/strong> \u2014 Truist Securities maintained its Hold rating and lowered its price target to US$24.00 from US$28.00.<\/p>\n

Whirlpool (WHR)<\/strong> \u2014 Citigroup maintained its Neutral rating.<\/p>\n

Whirlpool (WHR)<\/strong> \u2014 Goldman Sachs maintained its Neutral rating and lowered its price target to US$41.00 from US$48.00.<\/p>\n

Williams-Sonoma (WSM)<\/strong> \u2014 UBS maintained its Neutral rating.<\/p>\n

Willis Towers Watson Public (WTW)<\/strong> \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to US$364.00 from US$378.00.<\/p>\n

WillScot (WSC)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and lowered its price target to US$21.00 from US$28.00.<\/p>\n

Wyndham Hotels & Resorts (WH)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$92.00 from US$91.00.<\/p>\n

Xylem (XYL)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Zebra Technologies (ZBRA)<\/strong> \u2014 Citigroup maintained its Buy rating.<\/p>\n

Zeta Global (ZETA)<\/strong> \u2014 Craig Hallum set a US$38.00 price target.<\/p>\n

Zeta Global (ZETA)<\/strong> \u2014 Roth Capital maintained its Buy rating and raised its price target to US$55.00 from US$44.00.<\/p>\n

ZIM Integrated Shipping Services (ZIM)<\/strong> \u2014 JPMorgan maintained its Underweight rating and raised its price target to US$22.00 from US$16.50.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) The October 12th U.S. analyst updates suggest a selective, cautious outlook, with price-target reductions outnumbering increases roughly two to one. Financials,…<\/p>\n","protected":false},"author":3,"featured_media":26601,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76171","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nU.S. Analyst Updates: October 12th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. Analyst Updates: October 12th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) The October 12th U.S. analyst updates suggest a selective, cautious outlook, with price-target reductions outnumbering increases roughly two to one. Financials,…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-12T19:54:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/01\/amazon_dkblue_noto_email_v2016_ca-main._CB468775011_.png\" \/>\n\t<meta property=\"og:image:width\" content=\"583\" \/>\n\t<meta property=\"og:image:height\" content=\"360\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"34 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"U.S. Analyst Updates: October 12th, 2026\",\"datePublished\":\"2026-10-12T19:54:40+00:00\",\"dateModified\":\"2026-10-12T19:54:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/\"},\"wordCount\":7632,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/\",\"name\":\"U.S. Analyst Updates: October 12th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-12T19:54:40+00:00\",\"dateModified\":\"2026-10-12T19:54:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U.S. Analyst Updates: October 12th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"U.S. Analyst Updates: October 12th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/","og_locale":"en_US","og_type":"article","og_title":"U.S. Analyst Updates: October 12th, 2026","og_description":"Analyst Ratings (USA) The October 12th U.S. analyst updates suggest a selective, cautious outlook, with price-target reductions outnumbering increases roughly two to one. Financials,…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-12T19:54:40+00:00","og_image":[{"width":583,"height":360,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/01\/amazon_dkblue_noto_email_v2016_ca-main._CB468775011_.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"34 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"U.S. Analyst Updates: October 12th, 2026","datePublished":"2026-10-12T19:54:40+00:00","dateModified":"2026-10-12T19:54:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/"},"wordCount":7632,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/","name":"U.S. Analyst Updates: October 12th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-12T19:54:40+00:00","dateModified":"2026-10-12T19:54:40+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-12th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"U.S. Analyst Updates: October 12th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76171"}],"version-history":[{"count":4,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76171\/revisions"}],"predecessor-version":[{"id":76185,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76171\/revisions\/76185"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/26601"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}